Thrombolysis in Anterior Versus Posterior Circulation Strokes: Timing of Recanalization, Ischemic Tolerance, and Other Differences
暂无分享,去创建一个
C. Molina | J. Álvarez-Sabín | R. Delgado-Mederos | M. Ribó | M. Rubiera | J. Pagola | E. Santamarina | O. Maisterra | G. Ortega | M. Quintana
[1] A. Alexandrov,et al. Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA , 2008, Neurology.
[2] C. Molina,et al. Timing of Recanalization After Microbubble-Enhanced Intravenous Thrombolysis in Basilar Artery Occlusion , 2007, Stroke.
[3] G. Ford. Intra-arterial thrombolysis is the treatment of choice for basilar thrombosis: con. , 2006, Stroke.
[4] C. Molina,et al. Temporal Profile of Recanalization After Intravenous Tissue Plasminogen Activator: Selecting Patients for Rescue Reperfusion Techniques , 2006, Stroke.
[5] H. Mattle,et al. Therapy of Basilar Artery Occlusion: A Systematic Analysis Comparing Intra-Arterial and Intravenous Thrombolysis , 2006, Stroke.
[6] Raquel Delgado-Mederos,et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. , 2006, Stroke.
[7] A. Algra,et al. Outcome in patients with basilar artery occlusion treated conventionally , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[8] M. Kaste,et al. Long-term outcome after intravenous thrombolysis of basilar artery occlusion. , 2004, JAMA.
[9] J. Ostrem,et al. Acute Basilar Artery Occlusion: Diffusion-Perfusion MRI Characterization of Tissue Salvage in Patients Receiving Intra-Arterial Stroke Therapies , 2004, Stroke.
[10] J. Arenillas,et al. Differential Pattern of Tissue Plasminogen Activator–Induced Proximal Middle Cerebral Artery Recanalization Among Stroke Subtypes , 2004, Stroke.
[11] J. Arenillas,et al. Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke , 2003, Circulation.
[12] K. Toyka,et al. Therapies , 2002, Journal of the Neurological Sciences.
[13] Erich Bluhmki,et al. Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Secondary Analysis of the European-Australasian Acute Stroke Study (ECASS II) , 2001, Stroke.
[14] A. Alexandrov,et al. Transcranial doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. , 2000, Stroke.
[15] M. Kaste,et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.
[16] J. Broderick,et al. Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes , 1992, Stroke.
[17] Gregory,et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. , 1988, Stroke.
[18] R. Adams,et al. Occlusion of the basilar artery; a clinical and pathological study. , 1946, Brain : a journal of neurology.
[19] K. Weissenborn,et al. Intra-arterial thrombolysis using rt-PA in patients with acute stroke due to vessel occlusion of anterior and/or posterior cerebral circulation , 2007, Neuroradiology.